BTW
Boston Trust Walden Portfolio holdings
AUM
$14B
1-Year Return
12.58%
This Quarter Return
+4.98%
1 Year Return
+12.58%
3 Year Return
+52.97%
5 Year Return
+115.22%
10 Year Return
+284.47%
AUM
$14B
AUM Growth
+$333M
(+2.4%)
Cap. Flow
-$19.4M
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
17.78%
Holding
384
New
12
Increased
132
Reduced
160
Closed
10
Top Buys
| 1 |
NVIDIA
NVDA
|
$29.3M |
| 2 |
Hubbell
HUBB
|
$27.6M |
| 3 |
Acuity Brands
AYI
|
$26M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$24.4M |
| 5 |
American Express
AXP
|
$23M |
Top Sells
| 1 |
Visa
V
|
$34.4M |
| 2 |
Analog Devices
ADI
|
$29.7M |
| 3 |
Hanover Insurance
THG
|
$29.3M |
| 4 |
UnitedHealth
UNH
|
$28.3M |
| 5 |
Toro Company
TTC
|
$24.6M |
Sector Composition
| 1 | Technology | 24.83% |
| 2 | Financials | 17.15% |
| 3 | Industrials | 14.26% |
| 4 | Healthcare | 12.8% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Manhattan Associates
MANH
$13B
| $276K | ﹤0.01% |
1,400
-11,522
| -89% | -$2.28M |
|
352
Ingredion
INGR
$8.24B
| $267K | ﹤0.01% |
1,972
| – | – |
|
353
Franklin Resources
BEN
$13B
| $262K | ﹤0.01% |
11,000
| – | – |
|
354
iShares MSCI USA Min Vol Factor ETF
USMV
$23.4B
| $260K | ﹤0.01% |
2,767
| – | – |
|
355
Novartis
NVS
$251B
| $259K | ﹤0.01% |
2,140
| – | – |
|
356
Dell
DELL
$84.4B
| $257K | ﹤0.01% |
+2,096
| New | +$257K |
|
357
LPL Financial
LPLA
$26.6B
| $255K | ﹤0.01% |
+680
| New | +$255K |
|
358
J.M. Smucker
SJM
$12B
| $254K | ﹤0.01% |
2,585
| – | – |
|
359
iShares Russell 1000 Growth ETF
IWF
$117B
| $244K | ﹤0.01% |
575
| – | – |
|
360
Labcorp
LH
$23.2B
| $236K | ﹤0.01% |
900
-31,689
| -97% | -$8.32M |
|
361
Solventum
SOLV
$12.6B
| $231K | ﹤0.01% |
3,043
-327
| -10% | -$24.8K |
|
362
Allstate
ALL
$53.1B
| $230K | ﹤0.01% |
1,144
| – | – |
|
363
Xcel Energy
XEL
$43B
| $228K | ﹤0.01% |
3,347
| – | – |
|
364
Advanced Drainage Systems
WMS
$11.5B
| $227K | ﹤0.01% |
+1,975
| New | +$227K |
|
365
Cigna
CI
$81.5B
| $220K | ﹤0.01% |
667
-40
| -6% | -$13.2K |
|
366
ITT
ITT
$13.3B
| $220K | ﹤0.01% |
+1,400
| New | +$220K |
|
367
CDW
CDW
$22.2B
| $216K | ﹤0.01% |
+1,211
| New | +$216K |
|
368
Vertex Pharmaceuticals
VRTX
$102B
| $216K | ﹤0.01% |
485
-125
| -20% | -$55.7K |
|
369
Kellanova
K
$27.8B
| $215K | ﹤0.01% |
2,700
| – | – |
|
370
iShares Core MSCI EAFE ETF
IEFA
$150B
| $212K | ﹤0.01% |
+2,544
| New | +$212K |
|
371
The Ensign Group
ENSG
$10B
| $208K | ﹤0.01% |
+1,350
| New | +$208K |
|
372
Brookfield Infrastructure Partners
BIP
$14.1B
| $203K | ﹤0.01% |
+6,050
| New | +$203K |
|
|
BRKL
373
DELISTED
Brookline Bancorp
BRKL
| $153K | ﹤0.01% |
14,500
| – | – |
|
374
VF Corp
VFC
$5.86B
| $137K | ﹤0.01% |
11,660
| – | – |
|
375
Core Laboratories
CLB
$592M
| – | – |
-610,889
| Closed | -$9.16M |
|